Open AccessSuggested risk factor for oral lichen planus arising after mRNA COVID ‐19 vaccination
Author(s) -
Zargaran Massoumeh
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.6126
Subject(s) - medicine , covid-19 , vaccination , oral lichen planus , dermatology , risk factor , virology , immunology , outbreak , pathology , disease , infectious disease (medical specialty)
A single dose of BNT162b2 vaccine is suggested for COVID‐19‐infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP).